| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expenses) | 37 | 34 | 4 | -664 |
| Net loss | -1,398 | -1,422 | -1,262 | -1,047 |
| Basic | 20,206,033 | 17,213,017 | 15,875,485 | 10,910,227 |
| Basic loss per common share | -0.07 | -0.08 | -0.08 | -0.1 |
| Diluted | 20,206,033 | 17,213,017 | 15,875,485 | 10,910,227 |
| Diluted loss per common share | -0.07 | -0.08 | -0.08 | -0.1 |
Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. (KAPA)